Hidradenitis Suppurativa Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Hidradenitis Suppurativa Market is segmented By Treatment (Biologics, Antibiotics, Others), By Route of Administration (Injectable, Oral, Topical), By....
Hidradenitis Suppurativa Market Size
Market Size in USD
CAGR10.1%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 10.1% |
| Market Concentration | Medium |
| Major Players | AbbVie Inc., Pfizer Inc., Novartis International AG, UCB Pharma, Eli Lilly and Company |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Hidradenitis Suppurativa Market Analysis
The hidradenitis suppurativa market is estimated to be valued at USD 800.5 Mn in 2024 and is expected to reach USD 1570.4 Mn by 2031, growing at a compound annual growth rate (CAGR) of 10.1% from 2024 to 2031. With increasing awareness about the disease and its treatment options, more patients are seeking medical help. Furthermore, recent pipeline drugs and combination therapies are expected to drive the market during the forecast period.